• Subject: re: predictions
  • From: John Earl <johnearl@xxxxxxxxxx>
  • Date: Mon, 8 Dec 1997 06:33:23 -0800

At 12:20 PM 1/4/97 EDT, Booth Martin wrote:
>I'd make one more prediction:
>
>This year or next Bill Gates will go into the hospital. Microsoft shares 
>will tumble in value.  He'll be fine, nothing serious.  The shares will 
>come right back up to value, or higher and President Clinton will relax.
>No change will be noticeable.
>
>But the question will be raised: Is there Microsoft after Bill?
>
>MIS managers will begin thinking about entrusting their whole data network 
>to a 12 to 15 year old company. (Which they should worry about, but I've 
>never heard the concern.)
>
>That's my prediction, and I'm sticking to it.
>
>* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
>* This is the Midrange System Mailing List!  To submit a new message,   *
>* send your mail to "MIDRANGE-L@midrange.com".  To unsubscribe from     *
>* this list send email to MAJORDOMO@midrange.com and specify            *
>* 'unsubscribe MIDRANGE-L' in the body of your message.  Questions      *
>* should be directed to the list owner / operator: david@midrange.com   *
>* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
>umidr
>
>

--

John Earl       Lighthouse Software Inc.
8514 71st NW    Gig Harbor, WA 98335
253-858-7388    johnearl@lns400.com

+---
| This is the Midrange System Mailing List!
| To submit a new message, send your mail to "MIDRANGE-L@midrange.com".
| To unsubscribe from this list send email to MIDRANGE-L-UNSUB@midrange.com.
| Questions should be directed to the list owner/operator: david@midrange.com
+---


This thread ...


Follow On AppleNews
Return to Archive home page | Return to MIDRANGE.COM home page

This mailing list archive is Copyright 1997-2019 by midrange.com and David Gibbs as a compilation work. Use of the archive is restricted to research of a business or technical nature. Any other uses are prohibited. Full details are available on our policy page. If you have questions about this, please contact [javascript protected email address].